6786-01-0090 (adv. 42010.0090); Decision regarding the risk assessment of a deliberate release (field trial) of genetically modified oilseed rape (Brassica napus L. ssp. oleifera) Ms8, Rf3 and Ms8 x Rf3, issued by the German Competent Authority

Fertile plant material has to be transported and stored in closed and clearly labelled repositories at any time outside the release site and laboratory. The label needs to distinctively describe the LMO. Especially during transport, the dispersal of seeds of the transgenic oilseed rape has to be prevented.
Tools used for sowing, harvesting and inactivation have to be cleaned after use in order to minimize the unintended dispersal of genetically modified seeds.

To comply with requirements of Directive 90/220/EEC, Gentechnikgesetz (German Gene Technology Act): reduce possibility of GMO spread/establishment.

-  type of decision: field trial
-  LMO: Ms8, Rf3 and Ms8 x Rf3
-  legal basis: Directive 90/220/EEC, Gentechnikgesetz (German Gene Technology Act)
-  scope: test of field performance of LMO
-  authorization valid from 22 July 1999 to 31 December 2007
-  locations: 8 experimental fields located in 8 village in Germany, for details refer to the German LMO/GMO location register ( https://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)
-  total size: 95.920 m²/year;
-  max. 11.510.400 LMO in total

-  There is no Summary Notification Information Format available on the Internet (WebSNIF) for B/DE/98/90

The decision on this deliberate release was made by the Robert Koch Institute (RKI).
The RKI was the competent national authority for the German Gene Technology Act before the competences were transferred to the Federal Office of Consumer Protection and Food Safety (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, BVL) on April 1st 2004. Deliberate releases that were authorized by the RKI prior to this date are now handled by the BVL.